Capital Rx

When you think about implementing a new #PBM, do any pain points come up? Maybe you cringe at the thought of migrating your data or you worry about member disruption? We know how difficult it can be to navigate that change. That’s why we’re excited to discuss Never Move Again™, a solution that empowers #plansponsors with 50,000 members or more to take control of their pharmacy benefits program, prioritizes financial alignment, and supports members through electronic infrastructure. Join us for our #webinar on September 19th to learn how you can unbundle #pharmacybenefits, meet your #fiduciary responsibilities, and ease member disruption by leveraging a modern platform, a 24/7/365, multilingual call center, and member cards that will never change. Register now! https://okt.to/4YbW3e

Prior Authorizations (PA) are often a pain point, but in #pharmacybenefits, they can help patients receive safe, efficacious, and cost-effective prescriptions. We chatted with Sara Izadi, PharmD (Chief Clinical Officer), Lorece Shaw, PharmD (Director of Prior Authorization), and Callie Burton-Callegari (Manager, Product) to dive into the PA process, learn about some misconceptions surrounding PAs, and discover how modern technology like JUDI® and its built-in Prior Authorization Tool (also known as PAT) is helping our team make the process more efficient and accurate. Read the article now!

In early August, we held our inaugural Partner Summit, bringing together Capital Rx team members, current clients, #pharmacybenefits professionals, and others in the #PBM world to discuss leading topics of consequence, like: 🩺 #ValueBasedHealthcare 📉 Evaluating PBMs to achieve sustainable #pharmacy cost trend reductions ⚡️ #M3P and the future of JUDI® 🏛️ Legislative insights and tips for navigating recent industry developments Check out our quick video recap of the Partner Summit below!

🚨 We've officially launched Never Move Again™, a future-proof framework for administering pharmacy benefit programs! We've been at the forefront of innovation in this industry for years, leveraging JUDI® to efficiently manage pharmacy benefit programs for payers with plans ranging from 100s of lives to hundreds of thousands. When we combine JUDI with proven member service excellence and the #freedom of choice regarding fulfillment services, large U.S. employers and health plans have a stable foundation to build on and true visibility into costs. They can achieve greater control over their pharmacy benefit programs and provide better health outcomes for plan members without the disruption that comes with implementation - they'll never have to move again. 🤝 #healthcareinnovation #alignmentmatters #PBM Read more about our new offering: https://okt.to/IfWJVZ

If you don't know what "the spreadsheet" is with respect to #PBMs and how they are chosen, then you're not alone. When we brought A. J. Loiacono, John O'Brien, PharmD, MPH, and Julie Patterson, PharmD on the #AstonishingHealthcare podcast, we discussed numerous details some may not know about #pharmacybenefits, especially during the procurement process -- including how benefits consultants fit into the equation, especially with respect to #rebates. 🎧 Listen to the full episode here: https://okt.to/D2y9YE

On this day, 104 years ago, the 19th Amendment was ratified, and women officially earned the right to vote in America. Here at Capital Rx, we are proud to celebrate the women in our organization who comprise and lead our teams, including our leadership, pharmacists, customer care coordinators, IT engineers, marketers, product managers, and everyone in between. We wish everyone a happy #WomensEqualityDay.

On this week's episode of the #AstonishingHealthcare podcast, we chatted with John O'Brien, PharmD, MPH & Julie Patterson, PharmD, PhD over at the National Pharmaceutical Council about #pharmaceuticalrebates! It was a ton of fun having A. J. Loiacono in the studio, too, as we dove into the NPC's recent survey results (link in the comments) and how traditional #PBM models and a rebate-hungry ecosystem have hurt plans and patients by driving up costs. Why are rebates and rebate guarantees important when choosing a new PBM? Who do they benefit? Who is offering objective advice? We covered all that and more. Make no mistake, if you're a #pharmacybenefits wonk (yep, we discuss NDC 11s 🙃) or want to learn more about how rebates work within the system, what AJ sees in the pharmacy claims data, why there's a move to separate #administration from fulfillment, or what else the team at NPC is working on, you'll love this episode! 🎧 Listen to the full podcast episode here: https://okt.to/TKP0Sh

Attention health #plansponsors! 🚨 Bloomberg Law's new article is a great read. Thanks to Lauren Clason for taking the time to speak with A. J. Loiacono during your due diligence and highlighting feedback from Teamsters Health & Welfare and Pension Trust Funds of Philadelphia and Vicinity on the savings achieved with our model (and their ability to consistently control costs over several years and solve problems without sacrificing member service), why employer groups are looking for alternative #PBM models, and some of the challenges and "lingering issues" stakeholders must deal with. #PharmacyBenefitAdministration #employeebenefits #HealthCareCosts https://okt.to/KDH31J

If you’re a large employer, you know that implementing a new #PBM isn’t always a walk in the park—it can be disruptive. That’s why we created Never Move Again™—a solution that empowers you to unbundle #pharmacybenefits while retaining a solid foundation of modern electronic infrastructure. This gives you control over your pharmacy benefits program without the worry of disrupting your members. Join our webinar on September 19th where Capital Rx’s co-founder & CEO, A. J. Loiacono, and SVP of Strategy, Josh Golden, will discuss how it’s possible to design a customized benefits strategy that meets your needs. Register now and save your spot: https://okt.to/cfSL1B #NeverMoveAgain #PharmacyBenefitAdministration

The seven deadly sins of #pharmacybenefitmanagement, courtesy of A. J. Loiacono, include: 𝗚𝗿𝗲𝗲𝗱, driven by profit from drug spend and maximized revenue at patients' expense 𝗦𝗹𝗼𝘁𝗵, where technological innovation has been ignored in favor of the status quo 𝗪𝗿𝗮𝘁𝗵, where competition has been suppressed at all costs 𝗚𝗹𝘂𝘁𝘁𝗼𝗻𝘆, when patients are steered toward #PBM-owned pharmacies, and patients are oversupplied You can see the others in the image below. Want to learn more about the importance of an aligned #PharmacyBenefitAdministration solution? Check out our blog on the subject here: https://okt.to/ehMvpQ